Cargando…
Pathway Profiling and Rational Trial Design for Studies in Advanced Stage Cervical Carcinoma: A Review and a Perspective
Multiple genetic abnormalities will have occurred in advanced cervical cancer and multiple targeting is likely to be needed to control tumor growth. To date, dominant therapeutic targets under scrutiny for cervical cancer treatment have been EGFR pathway and angiogenesis inhibition as well as anti-H...
Autores principales: | Scholl, Susy M. E., Kenter, Gemma, Kurzeder, Christian, Beuzeboc, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195803/ https://www.ncbi.nlm.nih.gov/pubmed/22091418 http://dx.doi.org/10.5402/2011/403098 |
Ejemplares similares
-
Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives
por: Beuzeboc, Philippe, et al.
Publicado: (2014) -
Precision medicine in cancer: challenges and recommendations from an EU-funded cervical cancer biobanking study
por: Samuels, Sanne, et al.
Publicado: (2016) -
Rational surgical neck management in total laryngectomy for advanced stage laryngeal squamous cell carcinomas
por: Böttcher, Arne, et al.
Publicado: (2020) -
Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma
por: Mehta, Akash M., et al.
Publicado: (2007) -
From prospective biobanking to precision medicine: BIO-RAIDs – an EU study protocol in cervical cancer
por: Ngo, Charlotte, et al.
Publicado: (2015)